Whitnell & Co. reduced its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 11.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 43,016 shares of the pharmacy operator’s stock after selling 5,796 shares during the period. Whitnell & Co.’s holdings in Walgreens Boots Alliance were worth $2,379,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in WBA. Sageworth Trust Co acquired a new position in Walgreens Boots Alliance in the second quarter valued at $27,000. Quest Capital Management Inc. ADV acquired a new position in Walgreens Boots Alliance in the third quarter valued at $31,000. First Interstate Bank increased its stake in Walgreens Boots Alliance by 228.1% in the second quarter. First Interstate Bank now owns 607 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 422 shares during the period. TRUE Private Wealth Advisors acquired a new position in Walgreens Boots Alliance in the second quarter valued at $38,000. Finally, Golden State Wealth Management LLC acquired a new position in Walgreens Boots Alliance in the second quarter valued at $38,000. 60.60% of the stock is owned by institutional investors and hedge funds.
In other news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the company’s stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $50.48, for a total value of $10,869,505.04. Following the completion of the transaction, the chief accounting officer now directly owns 357,851 shares in the company, valued at $18,064,318.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 15.73% of the stock is currently owned by corporate insiders.
Shares of Walgreens Boots Alliance stock traded up $0.57 on Friday, reaching $59.24. 5,450,000 shares of the stock were exchanged, compared to its average volume of 5,855,335. Walgreens Boots Alliance Inc has a 1-year low of $49.03 and a 1-year high of $86.31. The company has a current ratio of 0.73, a quick ratio of 0.36 and a debt-to-equity ratio of 0.46. The business has a fifty day moving average price of $55.10 and a two-hundred day moving average price of $53.53. The firm has a market capitalization of $54.63 billion, a PE ratio of 9.89, a PEG ratio of 1.53 and a beta of 0.87.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Monday, October 28th. The pharmacy operator reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. Walgreens Boots Alliance had a net margin of 2.91% and a return on equity of 21.99%. The firm had revenue of $33.95 billion during the quarter, compared to analyst estimates of $33.88 billion. During the same quarter in the prior year, the business posted $1.48 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 1.5% compared to the same quarter last year. Research analysts expect that Walgreens Boots Alliance Inc will post 5.93 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be paid a $0.458 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.83 annualized dividend and a dividend yield of 3.09%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 30.55%.
A number of research firms have commented on WBA. Morgan Stanley dropped their price objective on shares of Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research note on Friday, August 23rd. Cleveland Research restated a “hold” rating on shares of Walgreens Boots Alliance in a research note on Monday, September 9th. Royal Bank of Canada lowered shares of Walgreens Boots Alliance to a “hold” rating and set a $59.00 price objective on the stock. in a research note on Friday, September 27th. Bank of America dropped their price objective on shares of Walgreens Boots Alliance from $51.00 to $50.00 and set an “underperform” rating on the stock in a research note on Thursday, October 3rd. Finally, Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a research note on Thursday, September 12th. They issued a “sell” rating on the stock. Five investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have given a buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $61.35.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.